JP2016507520A5 - - Google Patents

Download PDF

Info

Publication number
JP2016507520A5
JP2016507520A5 JP2015555242A JP2015555242A JP2016507520A5 JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5 JP 2015555242 A JP2015555242 A JP 2015555242A JP 2015555242 A JP2015555242 A JP 2015555242A JP 2016507520 A5 JP2016507520 A5 JP 2016507520A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
hbc
seq
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016507520A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/012586 external-priority patent/WO2014116730A2/en
Publication of JP2016507520A publication Critical patent/JP2016507520A/ja
Publication of JP2016507520A5 publication Critical patent/JP2016507520A5/ja
Pending legal-status Critical Current

Links

JP2015555242A 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド Pending JP2016507520A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361755850P 2013-01-23 2013-01-23
US61/755,850 2013-01-23
US201361901243P 2013-11-07 2013-11-07
US61/901,243 2013-11-07
PCT/US2014/012586 WO2014116730A2 (en) 2013-01-23 2014-01-22 Stabilized hepatitis b core polypeptide

Publications (2)

Publication Number Publication Date
JP2016507520A JP2016507520A (ja) 2016-03-10
JP2016507520A5 true JP2016507520A5 (enExample) 2017-03-30

Family

ID=51228185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555242A Pending JP2016507520A (ja) 2013-01-23 2014-01-22 安定化されたb型肝炎コアポリペプチド

Country Status (5)

Country Link
US (1) US9896483B2 (enExample)
EP (1) EP2948469A4 (enExample)
JP (1) JP2016507520A (enExample)
CA (1) CA2936092A1 (enExample)
WO (1) WO2014116730A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
US10526376B2 (en) 2015-01-15 2020-01-07 University Of Copenhagen Virus-like particle with efficient epitope display
DK3368068T3 (da) 2015-10-30 2021-02-22 Univ Copenhagen Viruslignende partikler med effektiv epitopdisplay
CN106636016B (zh) * 2017-02-24 2020-03-17 天津大学 一种通过正负电荷引入辅助病毒样颗粒自组装的方法和应用
WO2019115635A1 (en) 2017-12-13 2019-06-20 Curevac Ag Flavivirus vaccine
CN113508125A (zh) * 2018-12-28 2021-10-15 小利兰·斯坦福大学托管委员会 工程化乙型肝炎核心多肽
CN109666067A (zh) * 2019-01-07 2019-04-23 中国科学院过程工程研究所 一种重组病毒样颗粒及其制备方法和用途
WO2020145901A1 (en) * 2019-01-11 2020-07-16 Agency For Science, Technology And Research Use of hla-a*11:01-restricted hepatitis b virus (hbv) peptides for identifying hbv-specific cd8+ t cells

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008601A1 (en) 1992-10-14 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
DE69535905D1 (de) 1994-07-15 2009-02-26 Coley Pharm Group Inc Immunomodulatorische Oligonukleotide
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5968767A (en) 1996-06-07 1999-10-19 Genentech, Inc. Methods for in vitro protein synthesis
WO1998035062A1 (en) 1997-02-07 1998-08-13 Lingappa Jaisri R Multistep, atp-dependent cell-free system for the assembly of human immunodeficiency virus capsids
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
JP4101888B2 (ja) 1997-06-06 2008-06-18 ダイナバックス テクノロジーズ コーポレイション 免疫刺激オリゴヌクレオチド、その組成物およびその使用方法
NZ506245A (en) * 1998-02-12 2003-08-29 Immune Complex Corp Strategically modified hepatitis b core proteins and their derivatives
AU770802B2 (en) 1998-10-21 2004-03-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Virus-like particles for the induction of autoantibodies
AU770225B2 (en) * 1998-12-04 2004-02-19 Biogen Idec Ma Inc. HBV core antigen particles with multiple immunogenic components attached via peptide ligands
US6994986B2 (en) 1999-03-17 2006-02-07 The Board Of Trustees Of The Leland Stanford University In vitro synthesis of polypeptides by optimizing amino acid metabolism
US6168931B1 (en) 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
US6337191B1 (en) 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US6548276B2 (en) 2000-09-06 2003-04-15 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
DK2322631T3 (en) 2001-04-19 2015-01-12 Scripps Research Inst Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
AU2002366710A1 (en) 2001-12-20 2003-07-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
ES2566761T3 (es) 2002-05-30 2016-04-15 The Scripps Research Institute Ligación de azidas y acetilenos catalizada por cobre
AU2003259912B2 (en) 2002-08-19 2008-10-23 The Board Of Trustees Of The Leland Stanford Junior University Improved methods of in vitro protein synthesis
EP1535927B1 (en) * 2002-09-06 2010-07-14 Advanced Life Science Institute, Inc. Hbv precore protein capable of forming particles
WO2004078928A2 (en) 2003-02-28 2004-09-16 The Johns Hopkins University T cell regulation
JP5022028B2 (ja) 2003-03-26 2012-09-12 サイトス・バイオテクノロジー・アクチェンゲゼルシャフト メラン−aペプチドアナログ−ウイルス様粒子コンジュゲート
CA2527877A1 (en) 2003-06-18 2005-01-13 The Scripps Research Institute Unnatural reactive amino acid genetic code additions
WO2005005614A2 (en) * 2003-07-03 2005-01-20 Pecos Labs, Inc. Combined b-cell and t-cell epitopes on vlp for improved vaccines
US20050054044A1 (en) 2003-07-18 2005-03-10 The Board Of Trustees Of The Leland Stanford Junior University Method of alleviating nucleotide limitations for in vitro protein synthesis
US7341852B2 (en) 2003-07-18 2008-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods of decoupling reaction scale and protein synthesis yield in batch mode
EP1678195A4 (en) 2003-10-08 2008-04-23 The Feinstein Inst Medical Res METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC B-CELL LEUKEMIA
US9410170B2 (en) 2003-11-20 2016-08-09 The Board Of Trustees Of The Leland Stanford Junior University Methods of in vitro protein synthesis
US20050170551A1 (en) 2004-02-04 2005-08-04 Strip David R. Manufacture of flat panel light emitting devices
CA2567741A1 (en) * 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
ES2666693T3 (es) 2004-09-21 2018-05-07 The Scripps Research Institute Incorporación in vivo de alquinil aminoácidos a proteínas en eubacterias
US9809824B2 (en) 2004-12-13 2017-11-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
EP2018156B1 (en) * 2006-04-07 2010-03-17 Chimeros, Inc. Compositions and methods for treating b- cell malignancies
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US20110129438A1 (en) 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
EP2035554B1 (en) 2006-06-29 2013-04-24 The Board of Trustees of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
US20090317861A1 (en) 2006-06-29 2009-12-24 Bundy Bradley C Cell-free synthesis of virus like particles
DK2064333T3 (da) 2006-09-08 2014-05-05 Ambrx Inc Suppressor-trna-transkription i hvirveldyrceller
EP2109682A4 (en) 2007-01-18 2012-05-09 Univ Leland Stanford Junior Enhanced cell-free synthesis of active proteins with disulfide bonds
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US8445706B2 (en) 2008-09-05 2013-05-21 Board Of Trustees Of Northern Illinois University Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
WO2010042755A2 (en) * 2008-10-08 2010-04-15 Chimeros Inc. Chimeric therapeutics, compositions, and methods for using same
US20100168402A1 (en) 2008-11-14 2010-07-01 Bundy Bradley C Direct Attachment of Polypeptides to Virus Like Particles
US8324149B2 (en) 2008-11-18 2012-12-04 The Board Of Trustees Of The Leland Stanford Junior University Encapsidation of heterologous entities into virus-like particles
WO2011057134A1 (en) 2009-11-05 2011-05-12 Novici Biotech Llc Generation of antigenic virus-like particles through protein-protein linkages
WO2011109422A2 (en) 2010-03-02 2011-09-09 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of cancer
JP2014527072A (ja) * 2011-09-09 2014-10-09 バイオメド リアルティー, エル.ピー. ウイルスタンパク質の集合を制御するための方法および組成物
EP2809345A4 (en) 2012-02-03 2015-11-25 Univ Emory IMMUNOSTIMULATING COMPOSITIONS, PARTICLES THEREFOR, AND USES THEREFOR
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
WO2014145932A2 (en) 2013-03-15 2014-09-18 Bullet Biotechnology, Inc. Specific multivalent virus-like particle vaccines and uses thereof
WO2015089114A1 (en) 2013-12-09 2015-06-18 Bullet Biotechnology, Inc. Specific virus-like particle-cpg oligonucleotide vaccines and uses thereof

Similar Documents

Publication Publication Date Title
JP2016507520A5 (enExample)
JP2015531407A5 (enExample)
JP2012095652A5 (enExample)
JP2005120106A5 (enExample)
MX2019004499A (es) Sistemas de replicón de virus recombinante y usos de estos.
RU2012122173A (ru) Варианты альбумина
RU2010108308A (ru) Способ получения гетерогенных белков
JP2019530466A5 (enExample)
JP2014221052A5 (enExample)
JP2020509751A5 (enExample)
RU2014101401A (ru) Антигены вируса гриппа h1n1 с широким спектром активности, оптимизированные с применением вычислительных средств
DK1885850T3 (da) Fremgangsmåde til fremstilling af D-psicose ved D-psicose-epimerase
RU2011128371A (ru) Модифицированные f протеины sv и способы их применения
JP2007197439A5 (enExample)
ZA202100386B (en) Influenza virus hemagglutinin mutants
JP2007513634A5 (enExample)
JP2020528760A (ja) 新規融合タンパク質の調製およびそのタンパク質合成の向上における使用
JP2014524241A5 (enExample)
JP2011152137A5 (enExample)
RU2014142785A (ru) Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вирусов гриппа h5n1 и h1n1
WO2006119516A3 (en) Expression of viral proteins in plants
RU2014135703A (ru) Оптимизированные с помощью компьютера антигены с широким спектром реактивности для вирусов гриппа h3n2, h2n2 и b
JP2014076042A5 (enExample)
MY197457A (en) Chimeric papillomavirus l1 protein
PH12021550898A1 (en) Virus-like particles of cmv modified by fusion